STEHLE; Gerd

Patent Applications and Registrations

Patent applications and USPTO patent grants for STEHLE; Gerd.The latest application filed is for "quinazoline derivatives for the treatment of cancer diseases".

Company Profile

0.12.13

STEHLE; Gerd - Ehingen DE
Stehle, Gerd - Heidelberg DE
Stehle; Gerd - Mannheim DE
Stehle; Gerd - Wieblingen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20180360834 - SOLCA; Flavio ; et al.	2018-12-20
Combination Treatment Of Cancer Comprising Egfr/her2 Inhibitors App 20180086744 - SOLCA; Flavio ; et al.	2018-03-29
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20170112835 - SOLCA; Flavio ; et al.	2017-04-27
Quinazoline derivatives for the treatment of cancer diseases Grant 9,539,258 - Solca , et al. January 10, 2	2017-01-10
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20150272954 - SOLCA; Flavio ; et al.	2015-10-01
Quinazoline derivatives for the treatment of cancer diseases Grant 9,089,571 - Solca , et al. July 28, 2	2015-07-28
Combination Treatment Of Cancer Comprising Egfr/her2 Inhibitors App 20140199298 - SOLCA; Flavio ; et al.	2014-07-17
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20130178487 - SOLCA; Flavio ; et al.	2013-07-11
Quinazoline derivatives for the treatment of cancer diseases Grant 8,404,697 - Solca , et al. March 26, 2	2013-03-26
Quinazoline Derivatives For The Treatment Of Cancer Diseases App 20090306044 - Solca; Flavio ; et al.	2009-12-10
Combination Treatment Of Cancer Comprising Egfr/her2 Inhibitors App 20090306101 - Solca; Flavio ; et al.	2009-12-10
Conjugate for differentiating between healthy and unhealthy tissue App 20050019263 - Sinn, Hannsjorg ; et al.	2005-01-27
Conjugate consisting of an active substance and a non-exogenous native protein Grant 6,812,209 - Sinn , et al. November 2, 2	2004-11-02
Conjugate comprising a folic acid antagonist and a carrier Grant 6,720,304 - Sinn , et al. April 13, 2	2004-04-13
Conjugate for treating inflammatory infectious and/or skin diseases Grant 6,706,713 - Sinn , et al. March 16, 2	2004-03-16
Conjugate comprising an active agent, a polypeptide and a polyether Grant 6,395,254 - Sinn , et al. May 28, 2	2002-05-28
Conjugate For Differentiating Between Healthy And Unhealthy Tissue App 20020037254 - SINN, HANNSJORG ; et al.	2002-03-28
Radiation detection device Grant 6,310,352 - Gross , et al. October 30, 2	2001-10-30
Conjugate consisting of an active substance and a non-exogeneous native protein App 20010012885 - Sinn, Hansjorg ; et al.	2001-08-09
Preparation of acid amides and metallization of compounds Grant 6,177,561 - Sinn , et al. January 23, 2	2001-01-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.